Keeping drug costs manageable

Drug pricing remains a key area of focus in the political as well as policy arena. Given its importance to plan sponsors, despite all the other challenges, we kept our sights firmly on helping clients manage costs. Prescription drugs remain the most cost-efficient part of health care, but only if people are getting the most effective drug at the lowest cost. We remained focused on lowest net cost and appropriate utilization, delivering results for clients in 2020.

Delivering results in 2020: 2.9 percent overall trend, 1.7 percent utilization, 1.2 percent price growth. Above another graphic with two parts. Part one: 34 percent of clients had negative trend. Part two: for tightly managed clients 0.6 percent per $10 per member per month (PMPM) than overall cohort.